Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients
Authors:
- Mo YangMYMo Yang
- Bo XiaoBXBo Xiao
- Li YangLYLi Yang
Open Access
- 1 May 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (19) , e6676
Abstract
We performed a systematic review and meta-analysis to assess the roles of SPECT, PET, and MRS in distinguishing primary central nervous system lymphoma (PCNSL) from other focal brain lesions (FBLs) in human immunodeficiency virus (HIV)-infected patients. PubMed, Scopus, and Medline were systematically searched for eligible studies from 1980 to 2016. Two authors extracted characteristics of patients and their lesions using predefined criteria. Eighteen studies on SPECT containing 667 patients, 6 studies on PET containing 108 patients, and 3 studies on MRS containing 96 patients were included. SPECT had a pooled sensitivity of 0.92 (95% CI: 0.85–0.96) and specificity of 0.84 (95% CI: 0.74–0.90) in differentiating PCNSL from other FBLs. For the 6 studies that used only pathology and/or serology as the gold standard, the pooled sensitivity was 0.85 (95% CI: 0.72–0.97) and the pooled specificity was 0.73 (95% CI: 0.54–0.92). SPECT has good diagnostic accuracy for discriminating PCNSL from other FBL-causing disorders in HIV patients. However, the actual sensitivity and specificity of SPECT may be lower than expected if only pathology and/or serology was used as the gold standard. PET may be superior but has less supporting clinical data and is more expensive.Keywords
This publication has 52 references indexed in Scilit:
- Usefulness of stereotactic biopsy and neuroimaging in management of HIV-1 Clade C associated focal brain lesions with special focus on cerebral toxoplasmosisClinical Neurology and Neurosurgery, 2013
- Reduced Value of Thallium-201 Single-Photon Emission Computed Tomography in the Management of HIV-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral TherapyAIDS Research and Human Retroviruses, 2004
- Inaccuracy of TI-201 Brain SPECT in Distinguishing Cerebral Infections from Lymphoma in Patients with AIDSClinical Nuclear Medicine, 2002
- SPECT Thallium-201 Combined with Toxoplasma Serology for the Presumptive Diagnosis of Focal Central Nervous System Mass Lesions in Patients with AIDSJournal of Infection, 2000
- Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS.Sexually Transmitted Infections, 1998
- Comparison between 201Tl-chloride and 99Tcm-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patientsNuclear Medicine Communications, 1998
- Differential Diagnosis of CNS Lesions in AIDS Patients by FDG-PETJournal of Computer Assisted Tomography, 1995
- Contrast-Enhanced Fast MRI in Differentiating Brain Toxoplasmosis and Lymphoma in AIDS PatientsJournal of Computer Assisted Tomography, 1994
- Diagnosis of intracranial lymphoma in patients with AIDS: value of 201TI single-photon emission computed tomography.American Journal of Roentgenology, 1994
- CT Appearance of Primary CNS Lymphoma in Patients with Acquired Immunodeficiency SyndromeJournal of Computer Assisted Tomography, 1991